cro.directory
← Compare landing

Chimera Biotec GmbH vs Swiss BioQuant AG

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/chimera-biotec/swissbioquant

CategoryChimera Biotec GmbHSwiss BioQuant AG
Listed sitecrocro
SummaryChimera Biotec offers GLP/GCP ultra-sensitive bioanalysis built on its proprietary Imperacer Immuno-PCR platform. Capabilities cover custom immunoassay development, assay transfer, and ADA/immunogenicity and PK/PD assays down to sub-pg/ml levels.Bioanalytical CRO offering LC-MS/MS and ligand-binding assay development, validation, and sample analysis for small and large molecules. Work runs in a 21 CFR Part 11 compliant environment, with qPCR support for gene therapy bioanalysis.
Services
  • Bioanalysis
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Analytical Method Development & Validation
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Biomarker Assays
  • Immunogenicity Assays (ADA / NAb)
  • In Vivo PK / PD Studies
Modalities
  • Biologics (Other)
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Peptide
  • Biologics (Other)
  • Gene Therapy
  • Cell Therapy
IndicationsData not yet provided.Data not yet provided.
LocationsData not yet provided.Data not yet provided.
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.